Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elena Rossini
Institutions:
Azienda Ospedaliera Sant'Andrea,
UCL Queen Square Institute of Neurology,
University College London,
Sapienza University of Rome
Observed institutions:
Universidade de São Paulo,
John Radcliffe Hospital,
Azienda Ospedaliera Sant'Andrea,
Oxford University Hospitals NHS Trust,
UCL Queen Square Institute of Neurology,
University College London,
Sapienza University of Rome
show all 7
ORCID:
0009-0002-7862-6743
Observed ORCID:
0009-0002-7862-6743
OpenAlex ID:
A5013934215
Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease
2024
·
Riccardo Currò
, Natalia Dominik
, et al.
·
Brain
·
43
PDF
Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies
2022
·
Laura Fionda
, Antonio Lauletta
, et al.
·
Journal of Neurology
·
34
PDF
Ravulizumab for generalized Myasthenia Gravis: a multicenter real-life experience
2025
·
Elena Rossini
, Vincenzo Di Stefano
, et al.
·
Journal of Neurology
·
20
PDF
Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study
2025
·
Vera Bril
, Artur Drużdż
, et al.
·
Journal of Neurology
·
16
Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors
2023
·
Laura Fionda
, Elena Rossini
, et al.
·
Neurological Sciences
·
16
Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study
2025
·
Vincenzo Di Stefano
, Nicasio Rini
, et al.
·
Journal of the Neurological Sciences
·
15
PDF
Emergent role of complement inhibitors in myasthenic crisis: Understanding why, when and how
2025
·
Elena Rossini
, Stefania Morino
, et al.
·
Clinical Neurology and Neurosurgery
·
14
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO)
2023
·
Luca Leonardi
, Rocco Costanzo
, et al.
·
Journal of the Peripheral Nervous System
·
13
PDF
Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now?
2025
·
Elena Rossini
, Luca Leonardi
, et al.
·
Brain Sciences
·
12
PDF
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study
2024
·
Laura Fionda
, Luca Leonardi
, et al.
·
Journal of Neurology
·
9
PDF
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients
2023
·
Laura Fionda
, Fiammetta Vanoli
, et al.
·
Neurological Sciences
·
9
PDF
Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience
2025
·
Sofia Marini
, Carmen Erra
, et al.
·
Frontiers in Immunology
·
6
PDF
Sporadic late-onset nemaline myopathy (SLONM): Data from a case series and literature review of 144 patients
2025
·
Antonio Lauletta
, Francesca Forcina
, et al.
·
Autoimmunity Reviews
·
5
Distal upper limb involvement in myasthenia-myositis association
2022
·
Antonio Lauletta
, Laura Fionda
, et al.
·
Neurological Sciences
·
5
Myasthenic syndromes: mistaking genetic for acquired
2025
·
Leighann Henehan
, Elena Rossini
, et al.
·
Practical Neurology
·
3
Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause?
2023
·
Antonio Lauletta
, Lanfranco De Carolis
, et al.
·
Neurological Sciences
·
3
Comparative Study of Sporadic and Immune Checkpoint Inhibitor–Related Forms of Myasthenia Gravis-Myositis Overlap Syndrome
2026
·
Antonio Lauletta
, Elena Rossini
, et al.
·
Neurology
·
2
suspected acute disseminated encephalomyelitis (ADEM) after ChAdOx1 nCoV-19 vaccine: A case report
2021
·
Virginia Rinaldi
, Gianmarco Bellucci
, et al.
·
Journal of the Neurological Sciences
·
1
Mitochondrial dysfunction in neurology: biomarkers and clinical implications
2026
·
Elena Rossini
, Matteo Garibaldi
, et al.
·
Nature Reviews Neurology
11O A comparative study of sporadic and immune checkpoint inhibitor-related forms of myasthenia gravis-myositis (MG-IM) overlap syndrome
2026
·
Antonio Lauletta
, Elena Rossini
, et al.
·
Neuromuscular Disorders
Prevalence and Geographical Distribution of Patients With Congenital Myasthenic Syndromes in the United Kingdom
2025
·
Elena Rossini
, Leighann Henehan
, et al.
·
Muscle & Nerve
PDF
Response to letter to the editor: “Emergent role of complement inhibitors in myasthenic crisis” (CNN-D-25-2224)
2025
·
Elena Rossini
, Stefania Morino
, et al.
·
Clinical Neurology and Neurosurgery
Response to comment on: “Emergent role of complement inhibitors in myasthenic crisis – Complement for crisis, FcRn for continuity (CNN-D-25–2177)”
2025
·
Elena Rossini
, Stefania Morino
, et al.
·
Clinical Neurology and Neurosurgery
Correction: Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study
2025
·
Laura Fionda
, Luca Leonardi
, et al.
·
Journal of Neurology
PDF
Show more works
View as search
Works count:
24
Citation count:
226
H-index:
9
I10-index:
9
Year
Topic
Type